Great event yesterday at the UnConference organised by CataloniaBio & HealthTech!
The event was focused on advanced therapies medicinal products (ATMPs), and posed a great opportunity to debate about the ground-breaking therapeutic possibilities they offer and their significant role in the pharmaceutical and biotech industry.
ASPHALION experts Núria Romero Carol and Oriol Penon, PhD attended the event, together with Christopher Mann, who joined one of the panel discussions about one of the challenges to be addressed: “How to improve market access and regulatory barriers for solutions in advanced therapies?”. Better competitiveness of companies, improved market access and regulatory pathway are key to get to increase the opportunity for patients to be treated with novel therapies and ensure technological sovereignty and supply.
At Asphalion we are experts! Contact us for any information on ATMPs at: [email protected]
